Most patients with disorders of gut-brain interaction receive pharmacotherapy with major or moderate drug-gene interactions

Revati Varma, Jeffrey P. Staab, Eric T. Matey, Jessica A. Wright, Brototo Deb, Konstantinos N. Lazaridis, Lawrence A. Szarka, Kent R. Bailey, Adil E. Bharucha

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Most patients with disorders of gut-brain interaction receive pharmacotherapy with major or moderate drug-gene interactions'. Together they form a unique fingerprint.

Medicine & Life Sciences